Related Experiment Video

Updated: Sep 9, 2025

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.2K

Variant-specific deep phenotyping as a tool to develop precision therapies

Rita Horvath1, Hanns Lochmüller2

  • 1Cambridge, UK.

Brain : a Journal of Neurology
|September 2, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.8K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.6K

Related Experiment Videos

Last Updated: Sep 9, 2025

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.2K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.8K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.6K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

Articles linked to this work by shared authors, journal, and citation graph.

The role of impaired mitochondrial function in neurological manifestations of mitochondrial diseases.

Mammalian genome : official journal of the International Mammalian Genome Society·2026

Neurological disease progression in adults with ataxia-telangiectasia: a longitudinal study.

Brain : a journal of neurology·2026

DYT-PRKRA Dystonia-Parkinsonism with Pathological Startle: Expanding the Phenotype of PRKRA-Related Disease.

Movement disorders clinical practice·2026

Hexosamine Pathway Disruption by GFPT1 Loss Drives Coordinated Defects in Glycosylation, Autophagy, and Trafficking.

Biomolecules·2026

Systematic reanalysis of next-generation sequencing data in 101 neuromuscular disorder families enhances diagnostic yield, reveals intronic variants, and identifies a novel disease gene.

Journal of neurology·2026

Muscle Strength, Balance, and Indoor Mobility in Oculopharyngeal Muscular Dystrophy: An Exploratory Canadian Multicenter Study.

Muscle & nerve·2026

Target engagement and efficacy in disease-modifying trials of synuclein-related disorders.

Brain : a journal of neurology·2026

The genetic landscape of myotonic dystrophy type 1: insights from nearly one million genomes.

Brain : a journal of neurology·2026

White matter hyperintensity burden in amyotrophic lateral sclerosis: motor and survival correlates.

Brain : a journal of neurology·2026

Nerve growth factor metabolic dysfunction in Down's syndrome brains.

Brain : a journal of neurology·2026

Mitochondrial DNA damage elicits PINK1 upregulation in pontine cholinergic neurons in Parkinson's disease.

Brain : a journal of neurology·2026

Blood-brain barrier opening with focused ultrasound reduces neuromelanin in a non-human primate model.

Brain : a journal of neurology·2026

Closing the diagnostic gap in transthyretin cardiac amyloidosis: red flags, modern imaging, and emerging therapies.

Frontiers in cardiovascular medicine·2026

Tumor-on-chip and cancer microphysiological platforms: knowledge structure, thematic evolution, and the emergence of organoid-integrated models, 2010-2025.

Frontiers in pharmacology·2026

Intensive sequential tDCS-rTMS over left DLPFC for biperiden dependence: A case report.

AIMS neuroscience·2026

New insight into Alzheimer's disease: small molecule-Aβ in the brain transport and peripheral organ clearance.

Frontiers in aging·2026

Transaxillary minimally invasive mitral valve surgery: early and mid-term outcomes in 763 patients.

Annals of cardiothoracic surgery·2026

An innovative hybrid cognitive behavioral therapy for insomnia approach to insomnia treatment: a retrospective chart review study.

Family practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us